Business
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management
SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering
About this update from Zhongchao Inc.
[{"type":"text","content":"SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) (\"Zhongchao\" or the \"Company\"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced it has achieved a milestone of serving over 10,000 breast cancer patients in China with comprehensive disease management services since 2021. By offering disease management services, Zhongchao aims to ensure effective medical treatments while reducing financial hardships and enhance the overall quality of life for these patients.\nRecently published statistics indicated a great need for disease management for breast cancer patients in China. The 2022 China Breast Cancer Follow-up and Health Management Guidelines highlighted the number of approximately 420,000 new breast cancer diagnoses in China in 2022, which ranked first and represented almost 20% of all malignant tumors diagnosed in women in China. As cure rates of breast cancer increased and the average survival time for is prolonged, there is an evident rising demand for life-long comprehensive disease management. Additionally, financial challenges arising from breast cancer treatment further called for such disease management. The 2022 China Breast Cancer Patient Quality of Life White Paper sheds light on the economic strains: breast cancer patients are burdened with an average treatment expense of RMB206,000, with out-of-pocket costs reaching up to RBM111,000 based on the questionnaires completed by breast cancer patients. Particularly, over 64% of these patients had households income of less than RBM100,000.\nZhongchao initiated its disease management services back in 2021 to alleviate financial burdens and facilitate treatment process for eligible breast cancer patients. In collaboration with multiple hospitals, pharmacies, pharmaceutical enterprises, non-profit organizations and insurance companies, Zhongchao provides various management services, including but not limited to, drug aids, disease follow-up visits, medication management, and cancer education. The Company's dedicated service team, accessible via a dedicated hotline, offers patient inquiries, medication assistance, medication usage and experience tracking, and sustained follow-up visits and management. From 2021 to 2023, Zhongchao's concerted efforts have aided over 10,000 br...